CARCINOMA TRANSITIONAL CELL
Clinical trials for CARCINOMA TRANSITIONAL CELL explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA TRANSITIONAL CELL trials appear
Sign up with your email to follow new studies for CARCINOMA TRANSITIONAL CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New bladder cancer drug put to the test in early study
Disease control TerminatedThis study tested a drug called enfortumab vedotin for people with a type of bladder cancer that hasn't spread into the muscle layer. The drug was placed directly into the bladder using a thin tube. The main goals were to check for side effects and see how the body handles the dr…
Matched conditions: CARCINOMA TRANSITIONAL CELL
Phase: PHASE1 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated May 17, 2026 05:32 UTC
-
Experimental bladder cancer drug combo shows promise but study halted early
Disease control TerminatedThis study tested an experimental drug called enfortumab vedotin, alone or with other cancer treatments, in people with advanced bladder or urinary tract cancer. The goal was to see if the drug could shrink tumors and to monitor side effects. The study included 348 participants b…
Matched conditions: CARCINOMA TRANSITIONAL CELL
Phase: PHASE1, PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated May 17, 2026 05:32 UTC